Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06831019 · ClinicalTrials.gov registry record

The ROAR Study: Reactive Oxygen Species and Reproduction

A clinical trial of Oxidative Stress and Ovarian Aging, sponsored by University of California, San Francisco.

Recruiting
Registry status
1,100
Enrollment target
1
Study location

NCT06831019 is a study of Oxidative Stress and Ovarian Aging that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 1,100 participants, above the 55-participant average among 36 other Oxidative Stress trials with a reported enrollment target (1900% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06831019, a study of Oxidative Stress and Ovarian Aging, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
1,100 participants
Enrollment target
1
Study location

Study Summary

This is a prospective cohort study characterizing follicular fluid and serum levels of oxidative stress in women with various infertility diagnoses undergoing in vitro fertilization, and assessing the relationship of oxidative stress to oocyte competence as determined by embryo development outcomes. Furthermore, we will measure oxidative stress in sperm and correlate the overall oxidative stress within the couple with IVF and pregnancy outcomes of the resultant embryos.

Interventions

  • DIAGNOSTIC_TEST Oxidative stress markers

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 1,100 participants
Start Date 2025-07-07
Est. Completion 2027-03-01

What the Registry Record Tells You About NCT06831019

The ClinicalTrials.gov registry entry for NCT06831019 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 55-participant average among 36 other Oxidative Stress trials with a reported enrollment target (1900% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Oxidative Stress appearing as the primary indexed condition, and to 1 intervention - of which Oxidative stress markers is the first listed.

NCT06831019 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06831019 about?

NCT06831019 is a clinical study titled "The ROAR Study: Reactive Oxygen Species and Reproduction". This is a prospective cohort study characterizing follicular fluid and serum levels of oxidative stress in women with various infertility diagnoses undergoing in vitro fertilization, and assessing the relationship of oxidative stress to oocyte competence as determined by embryo development outcomes....

What is the current status of trial NCT06831019?

This trial is currently recruiting. The enrollment target is 1,100 participants. The study started on 2025-07-07. Estimated completion is 2027-03-01.

What conditions does trial NCT06831019 study?

This clinical trial studies the following conditions: Oxidative Stress, Ovarian Aging, IVF Outcome.

What interventions are being tested in trial NCT06831019?

The interventions under investigation include: Oxidative stress markers (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06831019?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06831019 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Oxidative Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.